Drug prices affect access to HIV/AIDS drugs

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.398, 2003-01, pp. : 15-15

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Access to HIV/AIDS drugs widens

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 334, 2001-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Pharma commits funds to broaden access to HIV/AIDS drugs

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 421, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Global access to HIV/AIDS drugs expanded with new alliance . . .

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 394, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

GSK cuts HIV/AIDS drug prices, Latin America cuts drug deal

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 418, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Anti-HIV Drug Development: Structural Features and Limitations of Present Day Drugs and Future Challenges in the Successful HIV/AIDS Treatment

By  

Current Pharmaceutical Design, Vol. 19, Iss. 10, 2013-03 ,pp. : 1767-1783

Bentham Science Publishers

Access to resources Recommend Favorite